Quantitative mitochondrial redox imaging of breast cancer metastatic potential

Journal of Biomedical Optics

Volumn 15, Issue 3, 2010, Pages

  Xu, He N ^a   Nioka, Shoko ^a   Glickson, Jerry D ^a   Chance, Britton ^a   Li, Lin Z ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Calibration; Mitochondrial redox state; NADH and oxidized flavoprotein; Optical imaging; Redox ratio

Indexed keywords

BREAST CANCER; BREAST TUMOR; CANCER RESEARCH; CLINICAL DIAGNOSIS; CLINICAL PRACTICES; DRUG DEVELOPMENT; FLUORESCENCE IMAGE; HUMAN BREAST; HUMAN BREAST CANCER; IN-VIVO; LOW TEMPERATURES; METASTATIC POTENTIAL; MITOCHONDRIAL REDOX STATE; MULTI SLICES; NADH AND OXIDIZED FLAVOPROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDES; OPTICAL IMAGING; REDOX RATIO; REDOX STATE; REFERENCE STANDARD; TUMOR TISSUES;

AMIDES; BIOLOGICAL MATERIALS; DIAGNOSIS; DISEASES; MAMMALS; TUMORS;

MITOCHONDRIA;

CONTRAST MEDIUM; FLAVOPROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; TUMOR MARKER;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL HYPOXIA; CHEMISTRY; CYTOCHEMISTRY; HUMAN; METABOLISM; METASTASIS; METHODOLOGY; MITOCHONDRION; MOUSE; NICK END LABELING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; SPECTROFLUOROMETRY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL HYPOXIA; CELL LINE, TUMOR; CONTRAST MEDIA; FLAVOPROTEINS; HISTOCYTOCHEMISTRY; HUMANS; IN SITU NICK-END LABELING; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MITOCHONDRIA; NAD; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OXIDATION-REDUCTION; SPECTROMETRY, FLUORESCENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954516693     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3431714     Document Type: Article

References (65)

1. I. J. Fidler, "The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited," Nat. Rev. Cancer 3(6), 453-458(2003). (Pubitemid 37328849)
2. M. B. Sporn, "The war on cancer: a review," Ann. N.Y. Acad. Sci. 833, 137-146 (1997). (Pubitemid 28045246)
3. P. T. Winnard, A. P. Pathak, S. Dhara, S. Y. Cho, V. Raman, and M. G. Pomper, "Molecular imaging of metastatic potential," J. Nucl. Med. 49, 96S-112S (2008). (Pubitemid 351948039)
4. F. Dong, A. S. Budhu, and X. W. Wang, "Translating the metastasis paradigm from scientific theory to clinical oncology," Clin. Cancer Res. 15(8), 2588-2593 (2009).
5. G. H. Heppner and F. R. Miller, "The cellular basis of tumor progression," Int. Rev. Cytol. 177, 1-56 (1998). (Pubitemid 128716720)
6. I. J. Fidler and M. L. Kripke, "Metastasis results from preexisting variant cells within a malignant tumor," Science 197(4306), 893-895 (1977). (Pubitemid 8168759)
7. I. J. Fidler and I. R. Hart, "Biological diversity in metastatic neoplasms: origins and implications," Science 217(4564), 998-1003 (1982). (Pubitemid 12059094)
8. G. H. Heppner, "Tumor heterogeneity," Cancer Res. 44(6), 2259-2265 (1984). (Pubitemid 14110633)
9. R. Alexandrova, "Tumor heterogeneity," Exp. Pathol. Parasitol. 4, 57-67 (2001).
10. B. Quistorff, J. C. Haselgrove, and B. Chance, "High spatial resolution readout of 3-D metabolic organ structure: an automated, lowtemperature redox ratio-scanning instrument," Anal. Biochem. 148(2), 389-400 (1985). (Pubitemid 15045396)
11. Y. Gu, Z. Qian, J. Chen, D. Blessington, N. Ramanujam, and B. Chance, "High-resolution three-dimensional scanning optical image system for intrinsic and extrinsic contrast agents in tissue," Rev. Sci. Instrum. 73(1), 172-178 (2002).
12. H. N. Xu, B. Wu, S. Nioka, B. Chance, and L. Z. Li, "Calibration of redox scanning for tissue samples," Proc. SPIE 7174, 71742F (2009).
13. L. Z. Li, H. N. Xu, M. Ranji, S. Nioka, and B. Chance, "Mitochondrial redox imaging for cancer diagnostic and therapeutic studies," J. Innov. Opt. Health Sci. 2, 325-341 (2009).
14. B. Chance, B. Schoener, R. Oshino, F. Itshak, and Y. Nakase, "Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals," J. Biol. Chem. 254(11), 4764-4771 (1979).
15. B. Chance and G. R. Williams, "Method for the localization of sites for oxidative phosphorylation," Nature 176(4475), 250-254 (1955).
16. B. Chance and G. R. Williams, "Respiratory enzymes in oxidative phosphorylation. 4. The respiratory chain," J. Biol. Chem. 217(1), 429-438 (1955).
17. B. Chance and H. Baltscheffsky, "Respiratory enzymes in oxidative phosphorylation. VII. Binding of intramitochondrial reduced pyridine nucleotide," J. Biol. Chem. 233(3), 736-739 (1958).
18. B. Chance, "Pyridine nucleotide as an indicator of the oxygen requirements for energy-linked functions of mitochondria," Circ. Res. 38(5 Suppl 1), I31-38 (1976).
19. B. Chance, P. Cohen, F. Jobsis, and B. Schoener, "Intracellular oxidation-reduction states in vivo," Science 137, 499-508 (1962).
20. I. Hassinen and B. Chance, "Oxidation-reduction properties of the mitochondrial flavoprotein chain," Biochem. Biophys. Res. Commun. 31(6), 895-900 (1968).
21. B. Chance, P. Cohen, F. Jobsis, and B. Schoener, "Localized fluorometry of oxidation-reduction states of intracellular pyridine nucleotide in brain and kidney cortex of the anesthetized rat," Science 136(3513), 325 (1962).
22. B. Chance, N. Oshino, T. Sugano, and A. Mayevsky, "Basic principles of tissue oxygen determination from mitochondrial signals," Adv. Exp. Med. Biol. 37A, 277-292 (1973).
23. B. Chance, "Optical method," Bull. Chin. Ceram. Soc. 20, 1-28 (1991).
24. B. Chance, "Spectrophotometric and kinetic studies of flavoproteins in tissues, cell suspensions, mitochondria and their fragments," in Flavins and Flavoproteins, E. C. Slater, Ed., pp. 498-510, Elsevier, Amsterdam (1966).
25. M. Ranji, S. Nioka, N. Xu, B. Wu, L. Z. Li, D. L. Jaggard, and B. Chance, "Fluorescent images of mitochondrial redox states in in situ mouse hypoxic ischemic intestines," J. Innov. Opt. Health Sci. 2, 365-374 (2009).
26. K. Sato, Y. Kashiwaya, C. A. Keon, N. Tsuchiya, M. T. King, G. K. Radda, B. Chance, K. Clarke, and R. L. Veech, "Insulin, ketone bodies, and mitochondrial energy transduction," FASEB J. 9(8), 651-658 (1995).
27. L. Z. Li, R. Zhou, H. N. Xu, L. Moon, T. Zhong, E. J. Kim, H. Qiao, R. Reddy, D. Leeper, B. Chance, and J. D. Glickson, "Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential," Proc. Natl. Acad. Sci. U.S.A. 106(16), 6608-6613 (2009).
28. C. M. Balch, A. C. Buzaid, S. J. Soong, M. B. Atkins, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. HoughtonJr., J. M. Kirkwood, K. M. McMasters, M. F. Mihm, D. L. Morton, D. S. Reintgen, M. I. Ross, A. Sober, J. A. Thompson, and J. F. Thompson, "Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma," J. Clin. Oncol. 19(16), 3635-3648 (2001). (Pubitemid 32786276)
29. E. A. Seftor, R. E. B. Seftor, and M. J. C. Hendrix, "Selection of invasive and metastatic subpopulations from a heterogeneous humanmelanoma cell-line," BioTechniques 9(3), 324-331 (1990). (Pubitemid 20281292)
30. J. M. Kozlowski, I. R. Hart, I. J. Fidler, and N. Hanna, "A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice," J. Natl. Cancer Inst. 72(4), 913-917 (1984). (Pubitemid 14131734)
31. M. J. C. Hendrix, E. A. Seftor, Y. W. Chu, K. T. Trevor, and R. E. B. Seftor, "Role of intermediate filaments in migration, invasion, and metastasis," Cancer Metastasis Rev. 15(4), 507-525 (1996). (Pubitemid 27067169)
32. M. J. Hendrix, E. A. Seftor, Y. W. Chu, R. E. Seftor, R. B. Nagle, K. M. McDaniel, S. P. Leong, K. H. Yohem, A. M. Leibovitz, F. L. Meyskens Jr., D. H. Conaway, D. R. Welch, L. A. Liotta, and W. Stetler-Stevenson, "Coexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potential," J. Natl. Cancer Inst. 84(3), 165-174 (1992).
33. A. M. Sieuwerts, J. G. Klijn, and J. A. Foekens, "Assessment of the invasive potential of human gynecological tumor cell lines with the in vitro Boyden chamber assay: influences of the ability of cells to migrate through the filter membrane," Clin. Exp. Metastasis 15(1), 53-62 (1997). (Pubitemid 27095152)
34. H. N. Xu, B. Wu, S. Nioka, B. Chance, and L. Z. Li, "Quantitative redox scanning of tissue samples using a calibration procedure," J. Innov. Opt. Health Sci. 2, 375-385 (2009).
35. R. L. Veech, "Mitochondrial bioenergetics in intact tissue," in Mitochondria in Health and Disease, C. D. Berdanier, Ed., pp. 65-94, Taylor & Francis, New York (2005).
36. A. K. Ghosh, D. Finegold, W. White, K. Zawalich, and F. M. Matschinsky, "Quantitative histochemical resolution of the oxidationreduction and phosphate potentials within the simple hepatic acinus," J. Biol. Chem. 257(10), 5476-5481 (1982).
37. H. N. Xu, R. Zhou, S. Nioka, B. Chance, J. D. Glickson, and L. Z. Li, "Histological basis of MR/optical imaging of human melanoma mouse xenografts spanning a range of metastatic potentials," Adv. Exp. Med. Biol. 645, 247-253 (2009).
38. D. Ranney, P. Antich, E. Dadey, R. Mason, P. Kulkarni, O. Singh, H. Chen, A. Constantanescu, and R. Parkey, "Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy," J. Controlled Release 109(1-3), 222-235 (2005). (Pubitemid 41737266)
39. R. B. Pedley, S. A. Hill, G. M. Boxer, A. A. Flynn, R. Boden, R. Watson, J. Dearling, D. J. Chaplin, and R. H. Begent, "Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate," Cancer Res. 61(12), 4716-4722 (2001). (Pubitemid 32691881)
40. D. P. Bradley, J. J. Tessier, S. E. Ashton, J. C. Waterton, Z. Wilson, P. L. Worthington, and A. J. Ryan, "Correlation of MRI biomarkers with tumor necrosis in Hras5 tumor xenograft in athymic rats," Neoplasia 9(5), 382-391 (2007). (Pubitemid 46799981)
41. L. R. Cavalli and B. C. Liang, "Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?," Mutat Res. 398(1-2), 19-26 (1998).
42. K. Ishikawa, N. Koshikawa, K. Takenaga, K. Nakada, and J. Hayashi, "Reversible regulation of metastasis by ROS-generating mtDNA mutations," Mitochondrion 8(4), 339-344 (2008).
43. R. A. Gatenby and R. J. Gillies, "Why do cancers have high aerobic glycolysis?," Nat. Rev. Cancer 4(11), 891-899 (2004). (Pubitemid 39472955)
44. P. Vaupel, M. Hockel, and A. Mayer, "Detection and characterization of tumor hypoxia using pO2 histography," Antioxid. Redox Signal 9(8), 1221-1235 (2007). (Pubitemid 47080831)
45. R. Moreno-Sanchez, S. Rodriguez-Enriquez, A. Marin-Hernandez, and E. Saavedra, "Energy metabolism in tumor cells," FEBS J. 274(6), 1393-1418 (2007). (Pubitemid 46333738)
46. Z. Chen, W. Lu, C. Garcia-Prieto, and P. Huang, "The Warburg effect and its cancer therapeutic implications," J. Bioenerg. Biomembr. 39(3), 267-274 (2007). (Pubitemid 47619379)
47. J.-W. Kim and C. V. Dang, "Cancer's molecular sweet tooth and the Warburg effect," Cancer Res. 66(18), 8927-8930 (2006). (Pubitemid 44521105)
48. M. G. Vander Heiden, L. C. Cantley, and C. B. Thompson, "Understanding the Warburg effect: the metabolic requirements of cell proliferation," Science 324(5930), 1029-1033 (2009).
49. A. Quon and S. S. Gambhir, "FDG-PET and beyond: molecular breast cancer imaging," J. Clin. Oncol. 23(8), 1664-1673 (2005). (Pubitemid 46211421)
50. M. MacManus and R. J. Hicks, "The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review," Int. J. Radiat. Oncol., Biol., Phys. 72(5), 1298-1306 (2008).
51. O. Warburg, "On the origin of cancer cells," Science 123(3191), 309-314 (1956).
52. R. J. DeBerardinis, J. J. Lum, G. Hatzivassiliou, and C. B. Thompson, "The biology of cancer: metabolic reprogramming fuels cell growth and proliferation," Cell Metab. 7(1), 11-20 (2008).
53. B. Chance and B. Hess, "Spectroscopic evidence of metabolic control," Science 129(3350), 700-708 (1959).
54. B. Chance and L. N. Castor, "Some patterns of the respiratory pigments of ascites tumors of mice," Science 116(3008), 200-202 (1952).
55. R. A. Nakashima, M. G. Paggi, and P. L. Pedersen, "Contributions of glycolysis and oxidative phosphorylation to adenosine 5(-triphosphate production in AS-30D hepatoma cells," Cancer Res. 44(12 Pt 1), 5702-5706 (1984). (Pubitemid 15183582)
56. M. Guppy, P. Leedman, X. Zu, and V. Russell, "Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells," Biochem. J. 364(Pt 1), 309-315 (2002). (Pubitemid 34538975)
57. D. S. Harischandra and D. Hockenbery, "Bioenergetic differences in breast cancer cell lines," in Proc. AACR Metabolism and Cancer Conf., La Jolla, California, September 13-16 (2009).
58. A. Aliaga, J. A. Rousseau, R. Ouellette, J. Cadorette, J. E. van Lier, R. Lecomte, and F. Benard, "Breast cancer models to study the expression of estrogen receptors with small animal PET imaging," Nucl. Med. Biol. 31(6), 761-770 (2004). (Pubitemid 38887758)
59. Z. Zhang, D. Blessington, H. Li, T. M. Busch, J. Glickson, Q. Luo, B. Chance, and G. Zheng, "Redox ratio of mitochondria as an indicator for the response of photodynamic therapy," J. Biomed. Opt. 9(4), 772-778 (2004).
60. M. Zhang, Z. Zhang, D. Blessington, H. Li, T. M. Busch, V. Madrak, J. Miles, B. Chance, J. D. Glickson, and G. Zheng, "Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters," Bioconjugate Chem. 14(4), 709-714 (2003). (Pubitemid 36875429)
61. B. Chance, "Was Warburg right? Or was it that simple?," Cancer Biol. Ther. 4(1), 125-126 (2005).
62. M. Wu, A. Neilson, A. L. Swift, R. Moran, J. Tamagnine, D. Parslow, S. Armistead, K. Lemire, J. Orrell, J. Teich, S. Chomicz, and D. A. Ferrick, "Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells," Am. J. Physiol.: Cell Physiol. 292(1), C125-136 (2007). (Pubitemid 46115126)
63. K. Ishikawa, K. Takenaga, M. Akimoto, N. Koshikawa, A. Yamaguchi, H. Imanishi, K. Nakada, Y. Honma, and J.-I. Hayashi, "ROSgenerating mitochondrial DNA mutations can regulate tumor cell metastasis," Science 320(5876), 661-664 (2008). (Pubitemid 351928347)
64. G. Helmlinger, F. Yuan, M. Dellian, and R. K. Jain, "Interstitial pH and pO(2) gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation," Nat. Med. 3(2), 177-182 (1997). (Pubitemid 27064702)
65. B. Zelent, T. Troxler, and J. M. Vanderkooi, "Temperature dependence for fluorescence of beta-NADH in glycerol/water solution and in trehalose/sucrose glass," J. Fluoresc. 17(1), 37-42 (2007). (Pubitemid 46034269)